CAS 56974-61-9
:Gabexate mesilate
Description:
Gabexate mesilate is a synthetic compound primarily known for its role as a protease inhibitor. It is often utilized in clinical settings to manage conditions related to excessive proteolytic activity, such as pancreatitis and certain surgical procedures. The substance is characterized by its ability to inhibit serine proteases, which are enzymes that play crucial roles in various physiological processes, including inflammation and coagulation. Gabexate mesilate is typically administered intravenously and is known for its relatively rapid onset of action. In terms of its chemical structure, it features a mesilate group, which enhances its solubility and bioavailability. The compound is generally well-tolerated, although potential side effects may include gastrointestinal disturbances and allergic reactions. Its pharmacological profile makes it a valuable therapeutic agent in managing acute and chronic conditions where protease activity is a concern. Overall, Gabexate mesilate exemplifies the application of synthetic compounds in modern medicine, particularly in the context of enzyme modulation.
Formula:C16H23N3O4·CH4O3S
InChI:InChI=1S/C16H23N3O4.CH4O3S/c1-2-22-15(21)12-7-9-13(10-8-12)23-14(20)6-4-3-5-11-19-16(17)18;1-5(2,3)4/h7-10H,2-6,11H2,1H3,(H4,17,18,19);1H3,(H,2,3,4)
InChI key:InChIKey=DNTNDFLIKUKKOC-UHFFFAOYSA-N
SMILES:C(OCC)(=O)C1=CC=C(OC(CCCCCNC(=N)N)=O)C=C1.S(C)(=O)(=O)O
Synonyms:- 39492-01-8
- 4-[[6-[(Aminoiminomethyl)Amino]-1-Oxohexyl]Oxyl]Benzoic Acid Ethyl Ester Mesylate Salt
- Arodate
- Arodate (TN)
- Benzoic acid, 4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-, ethyl ester, monomethanesulfonate
- Benzoic acid, 4-[[6-[(aminoiminomethyl)amino]-1-oxohexyl]oxy]-, ethyl ester, methanesulfonate (1:1)
- Ethyl p-(6-guanidinohexanoxyloxy)benzoate methanesulfonate
- Ethyl p-(6-guanidinohexanoyloxy) benzoate methanesulfonate
- Ethyl p-hydroxybenzoate 6-guanidinohexanoate
- FOY
- Foy 007
- Foy-S 983
- Gabexate mesilate
- Gabexate mesilate (JP14)
- Gabexate monomethanesulfonate
- Gabexato [INN-Spanish]
- Gabexato mesilato [Spanish]
- Gabexatum [INN-Latin]
- Megacart
- Megacert
- Mesyl gabexate
- Methanesulfonate
- Reminaron
- [N-[5-(4-ethoxycarbonylphenoxy)carbonylpentyl]carbamimidoyl]azanium
- p-Hydroxybenzoic acid ethyl ester 6-guanidinohexanoate mesilate
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 11 products.
Gabexate Mesylate
CAS:Formula:C16H23N3O4·CH4O3SPurity:>97.0%(N)Color and Shape:White to Almost white powder to crystalMolecular weight:417.48Benzoic acid, 4-[[6-[(aminoiminomethyl)amino]-1-oxohexyl]oxy]-, ethylester, monomethanesulfonate
CAS:Formula:C17H27N3O7SPurity:98%Color and Shape:SolidMolecular weight:417.4772Gabexate mesylate
CAS:<p>Gabexate mesylate (FOY) inhibits thrombin, plasmin, kallikrein; used for pancreatitis, DIC, hemodialysis anticoagulant.</p>Formula:C17H27N3O7SPurity:99.2% - 99.64%Color and Shape:White CrystalMolecular weight:417.48Gabexate mesylate
CAS:<p>Gabexate mesylate</p>Formula:C16H23N3O4·CH3SO3HPurity:99%Color and Shape: white solidMolecular weight:417.48g/molGabexate mesylate
CAS:Formula:C16H23N3O4·CH4O3SPurity:(HPLC) ≥ 98.0%Color and Shape:White to off-white crystalline powderMolecular weight:417.48Gabexate mesylate
CAS:Controlled Product<p>Applications Gabexate mesylate is used in combination with somatostatin and octreotide in the treatment of severe acute pancreatitis in elderly patients.<br>References Li, X., et al.: Xiandai Zhenduan Yu Zhiliao, 25, 3719 (2014); Wei, Q., et al.: Xiandai Zhenduan Yu Zhiliao, 25, 5346 (2014)<br></p>Formula:C16H23N3O4·CH4O3SColor and Shape:NeatMolecular weight:417.48Gabexate mesylate
CAS:<p>Serine protease inhibitor</p>Formula:C17H27N3O7SPurity:Min. 95%Molecular weight:417.15697Ethyl 4-((6-guanidinohexanoyl)oxy)benzoate methanesulfonate
CAS:Purity:98%Molecular weight:417.480011Gabexate Mesylate
CAS:Controlled Product<p>Applications Gabexate Mesylate is a serine protease inhibitor. Gabexate Mesylate inhibits trypsin, plasmin, plasma kallikrein and thrombin. Gabexate Mesylate inhibits lipopolysaccharide-induced tumor necrosis factor-α (TNF-α) production through nuclear factor-κB and activator protein-1 activation. Neuroresearch & Neuroprotective Product.<br>References Yuksel, M. et al.: J. Pharmacol. Exp. Therap., 305, 298 (2003); Tamura, Y. et al.: Biochim. Biophys. Acta, 484, 417 (1977); Ohno, H. et al.: Thromb. Res., 24, 445 (1981);<br></p>Formula:C16H23N3O4·CH4O3SColor and Shape:NeatMolecular weight:417.48









